Bio-Rad Laboratories Inc (BIO)
331.77
-0.33
(-0.10%)
USD |
NYSE |
Sep 27, 16:00
331.73
-0.04
(-0.01%)
Pre-Market: 20:00
Bio-Rad Laboratories Research and Development Expense (Annual): 247.43M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 247.43M |
| December 31, 2022 | 256.89M |
| December 31, 2021 | 260.64M |
| December 31, 2020 | 217.76M |
| December 31, 2019 | 202.71M |
| December 31, 2018 | 199.20M |
| December 31, 2017 | 250.16M |
| December 31, 2016 | 205.71M |
| December 31, 2015 | 192.97M |
| December 31, 2014 | 220.33M |
| December 31, 2013 | 210.95M |
| December 31, 2012 | 209.20M |
| December 31, 2011 | 177.60M |
| December 31, 2010 | 172.27M |
| December 31, 2009 | 163.58M |
| Date | Value |
|---|---|
| December 31, 2008 | 159.52M |
| December 31, 2007 | 148.19M |
| December 31, 2006 | 127.48M |
| December 31, 2005 | 115.10M |
| December 31, 2004 | 108.34M |
| December 31, 2003 | 91.27M |
| December 31, 2002 | 79.79M |
| December 31, 2001 | 76.54M |
| December 31, 2000 | 68.14M |
| December 31, 1999 | 51.21M |
| December 31, 1998 | 41.38M |
| December 31, 1997 | 46.10M |
| December 31, 1996 | |
| December 31, 1995 | 34.70M |
| December 31, 1994 | 30.20M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
202.71M
Minimum
2019
260.64M
Maximum
2021
237.09M
Average
247.43M
Median
2023
Research and Development Expense (Annual) Benchmarks
| Agilent Technologies Inc | 481.00M |
| Bruker Corp | 294.80M |
| Avantor Inc | -- |
| Azenta Inc | 33.96M |
| Harvard Bioscience Inc | 11.76M |